Laura Brege, Director at Mirum Pharmaceuticals, Inc. (MIRM), bought 10,000 shares at $11.22 ($112K) on 2019-09-10, disclosed to the SEC on 2019-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PCRX | BUY | 2024-08-19 | $13K | — | Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |